You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AT2-receptor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in Petach Tikva (no intervantion)

Active, not recruiting
  • COVID-19
  • no intervantion
  • Petach Tikva, Israel
    Schneider Children's Medical Center
Sep 29, 2022

Breast Cancer Trial in Birmingham (Letrozole, Everolimus, TRC105)

Active, not recruiting
  • Breast Cancer
  • Birmingham, Alabama
    University of Alabama at Birmingham
Dec 13, 2022

Primary Immune Thrombocytopenia (ITP) Trial (Ianalumab)

Not yet recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • Ianalumab
  • (no location specified)
Jun 5, 2023

Early-stage Breast Cancer, HER2 Positive Breast Cancer, Hormone Receptor Positive Trial (Neratinib, Loperamide, Colesevelam)

Not yet recruiting
  • Early-stage Breast Cancer
  • +2 more
  • (no location specified)
Aug 5, 2022

Breast Cancer Trial (Diagnostic microprobe (inPROBE) medical device)

Recruiting
  • Breast Cancer
  • Diagnostic microprobe (inPROBE) medical device
  • Kraków, Poland
  • +1 more
Nov 2, 2022

Mechanisms of Pregnancy Vascular Adaptations

Recruiting
  • Pre-Eclampsia
  • Vascular Diseases
  • Omental Biopsy
  • Madison, Wisconsin
    UnityPoint Health-Meriter Hospital
Nov 1, 2022

Fanconi Anemia, Severe Aplastic Anemia, MDS Trial in Minneapolis (Total Body Irradiation (TBI) (Plan 1), Cyclophosphamide (CY)

Recruiting
  • Fanconi Anemia
  • +2 more
  • Total Body Irradiation (TBI) (Plan 1)
  • +8 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 2, 2022

Metastatic Breast Cancer (MBC) Trial in Nanjing, Shanghai (Paclitaxel Polymeric Micelles for Injection, Eribulin Mesilate

Recruiting
  • Metastatic Breast Cancer (MBC)
  • Paclitaxel Polymeric Micelles for Injection
  • +5 more
  • Nanjing, Jiangsu, China
  • +2 more
Nov 21, 2023

Neuroblastoma, Osteosarcoma Trial in Chapel Hill (iC9.GD2.CAR.IL-15 T-cells, Cyclophosphamide, Fludarabine)

Recruiting
  • Neuroblastoma
  • Osteosarcoma
  • iC9.GD2.CAR.IL-15 T-cells
  • +2 more
  • Atlanta, Georgia
  • +1 more
Jan 4, 2023

Type2Diabetes, ASCVD Trial (SGLT2 inhibitor, GLP-1 receptor agonist, Combination drug)

Recruiting
  • Type2Diabetes
  • ASCVD
  • SGLT2 inhibitor
  • +2 more
  • New York, New York
  • +1 more
Dec 19, 2022

HER2-positive Breast Cancer, Invasive Carcinoma of the Breast, Breast Cancer Trial in United States (Pertuzumab+TRASTUZUMAB,

Recruiting
  • HER2-positive Breast Cancer
  • +5 more
  • Pertuzumab+TRASTUZUMAB
  • ADJUVANT ENDOCRINE THERAPY
  • Stamford, Connecticut
  • +21 more
Dec 12, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Birmingham, Alabama
  • +12 more
Nov 9, 2022

ST Elevation Myocardial Infarction Trial in Geneva (Successful primary PCI, defined as primary PCI of the culprit lesion with =1

Not yet recruiting
  • ST Elevation Myocardial Infarction
  • Successful primary PCI, defined as primary PCI of the culprit lesion with ≥1 Abluminus NP polymer-free sirolimus-based nanocarrier eluting stent (Concept Medical Inc., India) implantation
  • Geneva, Switzerland
    Geneva University Hospitals
Mar 25, 2023

Breast Cancer Trial (SHR-1316 at a dose 20mg/kg q3w, SHR6390 at a dose of 150mg orally, daily, SBRT)

Recruiting
  • Breast Cancer
  • SHR-1316 at a dose 20mg/kg q3w
  • +2 more
  • Shenyang, Liaoning, China
    Shengjing Hospital of China Medical University
Sep 12, 2022

Based on Data From German Sick Funds That Looks at Costs of

Completed
  • Diabetes Mellitus, Type 2
  • Ingelheim am Rhein, Germany
    Boehringer Ingelheim
Jan 18, 2022

Malignant Solid Tumor Trial in Nashville (Ifetroban Sodium, Placebo)

Recruiting
  • Malignant Solid Tumor
  • Ifetroban Sodium
  • Placebo
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Jun 23, 2022

MT2017-45: CAR-T Cell Therapy for Heme Malignancies

Recruiting
  • Acute Lymphoblastic Leukemia
  • Large B-cell Lymphoma
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 2, 2022

Cardiorenal Syndrome (CRS) Trial in Rochester (Candesartan, Placebo)

Completed
Has Results
  • Cardiorenal Syndrome (CRS)
  • Rochester, Minnesota
    Mayo Clinic
Oct 20, 2021

Lymphoma, B-Cell Trial in Langfang (CD19 and CD22 targeted CAR-T cells)

Not yet recruiting
  • Lymphoma, B-Cell
  • CD19 and CD22 targeted CAR-T cells
  • Langfang, Hebei, China
    Hebei Yanda Ludaopei Hospital
Dec 6, 2022

Breast Tumors Trial in Israel, Korea, Republic of, United States (Atezolizumab (MPDL3280A), an engineered anti-programmed

Active, not recruiting
  • Breast Neoplasms
  • Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (PD-L1) antibody
  • +7 more
  • Birmingham, Alabama
  • +26 more
Dec 21, 2022

Oxygenation Instability and Maturation of Control of Breathing

Recruiting
  • Infant,Premature
  • Assessment of oxygenation instability
  • +5 more
  • Miami, Florida
    NICU at Holtz Children's Hospital
Jun 9, 2022

Leukemia, Myeloid, Acute Trial in United States (VCAR33)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • VCAR33
  • La Jolla, California
  • +9 more
Aug 14, 2023

Breast Cancer Trial in United States (Palbociclib, Aromatase Inhibitor)

Completed
Has Results
  • Breast Cancer
  • San Francisco, California
  • +9 more
Mar 18, 2022

Breast Cancer Trial in United States (T-DM1)

Active, not recruiting
  • Breast Cancer
  • Duarte, California
  • +13 more
Aug 25, 2022

HER2-positive Breast Cancer Trial in Birmingham ([18F]-FDG)

Recruiting
  • HER2-positive Breast Cancer
  • Birmingham, Alabama
    The University of Alabama at Birmingham
Jan 31, 2022